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Albuminuria is a key marker of renal injury and a major risk
factor for cardiovascular disease. In vivo imaging techniques
with fluorescent albumin have allowed visualization of its
movement within the whole kidney but they could not
distinguish between intact and degraded albumin.
To visualize albumin degradation in proximal tubular cells
in vivo we used an albumin conjugate (dye quenched
(DQ)-albumin), which only fluoresces when it is degraded. In
cultured proximal tubule cells, the fluorescent signal from
DQ-albumin was dependent on endocytosis and lysosomal
function and showed that at any time about 40% of
endocytosed DQ-albumin was degraded. Significant
accumulation of conventional Texas Red-labeled albumin and
degraded DQ-albumin was found in rat proximal tubules
5 min after injection. Importantly, no hint of DQ-albumin was
detected in the serum, suggesting that the fluorescent signal
in the proximal tubules was derived from tubular
degradation of intact albumin. Our study shows that
DQ-albumin, together with conventional fluorescent
conjugates of intact albumin, can be used to visualize
albumin degradation by proximal tubules in vivo.
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Albuminuria is an important marker of renal injury. Even
low levels of urinary albumin excretion (microalbuminuria)
is an independent risk factor for the development of
cardiovascular disease.1 Thus, a detailed understanding of
the molecular basis of renal albumin handling will provide
fundamental insights into the development and progression
of proteinuric renal disease and cardiovascular disease.
The traditional model for renal albumin handling is that
the glomerulus acts as a charge and size selective barrier such
that in the normal kidney, only small amounts of albumin
enter the tubule.2 This filtered albumin in then reabsorbed by
proximal tubular cells by endocytosis and subsequently
degraded in lysosomes to its constituent amino acids so that
only a trace amount of intact albumin is excreted in the final
urine (2–20 mg/day in humans). The increased urinary
excretion of immune-reactive albumin that defines micro-
albuminuria is thought to be because of breakdown of the
glomerular barrier, with the glomerulus becoming ‘leaky’ for
plasma albumin, and the increased levels of filtered albumin
saturate the capacity of the tubular endocytic pathway. This
also points to a potential role for dysregulation of tubular
endocytosis or lysosomal function in the pathogenesis of
microalbuminuria.
Considerable research over the last decade has focused on
the dynamics of receptor-mediated albumin endocytosis and
the molecular mechanisms underlying this process have been
described in some detail (reviewed in Refs. 2,3). Many studies
in both cultured proximal tubule cells and in vivo have used
fluorescent analogues of albumin to visualize the movement
of albumin following its uptake. More recently, in vivo
imaging techniques using confocal and two-photon micro-
scopy have been used to visualize albumin uptake by the
proximal tubule in intact kidneys in live animals.4,5 These
studies have generated considerable debate by proposing a
model in which glomeruli filter significant amounts of
albumin and that the proximal tubule reabsorbs most of this
filtered albumin intact to the blood by a high-capacity
transcytotic retrieval pathway.3,6 Thus the delineation
between degradative and retrieval pathways is of prime
importance. However, little experimental data exist regarding
the dynamics of albumin degradation in the proximal tubule
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and how this pathway is affected by pathophysiological
conditions or disease. The kidney is known to have the
highest lysosomal content of any tissue.7 The potential
importance of lysosomal degradation of filtered albumin is
highlighted by a small number of studies that report a
pronounced inhibition of albumin degradation in diabetes.8,9
Previously, it has not been possible to distinguish between
fluorescence arising from intact versus fragmented albumin
because the conjugated albumin molecule has several
fluorophores attached. The ability to visualize the spatial
distribution of degraded and intact albumin in the intact
kidney would enable a new understanding of renal albumin
handling in normal and diseased kidneys. In this study, we
describe and validate the use of autoquenching (dye
quenched (DQ)) fluorescent albumin conjugates as experi-
mental tools to investigate the degradation of albumin in the
proximal tubule both in vitro and in vivo.
RESULTS
Validation of DQ-albumin as a probe
DQ-bovine serum albumin (hereafter called DQ-albumin;
Molecular Probes, Eugene, OR, USA) is a bovine serum
albumin conjugate labeled to such a high degree with either
red or green BODIPY dyes that the dye is selfquenching and
therefore displays no detectable fluorescence. In other words,
intact DQ-albumin does not fluoresce. However, upon
proteolysis the quenching effect is abolished, resulting in
highly fluorescent albumin fragments.10 In our initial
experiments using a fluorescence microplate reader, we
confirmed that intact DQ-albumin displayed no detectable
fluorescence. Tryptic digestion of DQ-albumin resulted in a
significant level of fluorescence that saturated with time
(Figure 1a) and was not affected by pH (Figure 1b).
Polyacrylamide gel electrophoresis was also performed on
the DQ-albumin exposed to trypsin. As expected, this
resulted in a progressive degradation of the albumin probe
with associated laddering observed on the gels with a strong
band appearing at the dye front, which corresponds to small
peptide fragments (Figure 1c). Fluorescent gel imaging
demonstrated the removal of autoquenching after trypsiniza-
tion. Given that the main aim of this study was to validate the
use of DQ-albumin in vivo, a critical control was to verify
that there was no significant degradation of the DQ-albumin
during the time that it was transiting in the blood. Therefore,
we collected serum from rats that had been injected with a
bolus of DQ-albumin for 5 min (see in vivo studies below for
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Figure 1 | Characterization of DQ-albumin. DQ-albumin fluorescence was measured using a BMG Fluostar Optima at 550 nm excitation
and 620 nm emission wavelengths. (a) DQ-albumin (50 mg/ml) was exposed to trypsin for 1 h. Fluorescence was measured at the indicated
time points. (b) DQ-albumin was exposed to trypsin at pH 5, 7, or 9 for 5 min at which point fluorescence was measured. (c) SDS–PAGE
analysis of DQ-albumin conjugates in the absence and presence of trypsin. Protein bands were visualized by Coomassie staining whereas
fluorescent bands were visualized using a Typhoon fluorescent imager. (d) Rat serum was analyzed before DQ-albumin injection and 5 min
after DQ-albumin injection. Samples were incubated in the absence and presence of trypsin for 5 min at which time fluorescence was
measured. Error bars represent the mean±s.e.m. of at least three independent experiments.
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details). Importantly, we were unable to detect any signal in
the serum; however, when the serum was treated with
trypsin, an immediate strong fluorescent signal was observed
(Figure 1d).
DQ-albumin fluorescence in cell culture
The opossum kidney (OK) proximal tubule cell line is widely
used to study albumin uptake in vitro. We used OK cells to
determine the extent to which DQ-albumin could be used to
visualize albumin degradation. OK cells were incubated with
increasing concentrations of DQ-albumin (20–2,000 mg/ml).
DQ-albumin accumulation within OK cells was saturable
with maximum fluorescence occurring at 720±82 mg/ml and
half-maximal at 75±12 mg/ml (Figure 2a). It has been
reported previously that unlabeled albumin can displace
fluorescently labeled albumin.11 Similarly, we found that the
DQ-albumin signal was decreased in the presence of
unlabeled albumin in a concentration dependent manner
(Figure 2b). We have previously reported that albumin
uptake is effectively abolished by disruption of the actin
cytoskeleton.12 Similarly, we found that treatment of OK cells
with latrunculin A (2 mM) resulted in a significant inhibition
of albumin degradation as shown by the reduction in DQ-
albumin fluorescence (38±9.1%; n¼ 3; Po0.01; Figure 2c).
Incubation with chloroquine (100 mM), an inhibitor of
lysosomal acidification, also caused a reduction in DQ-
albumin fluorescence (88±7%; n¼ 3; Po0.001; Figure 2c).
Thus, the characteristics of the uptake and fluorescence of
DQ-albumin are remarkably similar to those of conventional
Texas Red-labeled albumin (TR-albumin). One key remain-
ing question is what percentage of the endocytosed albumin
is actually degraded? To answer this question, OK cells were
incubated with DQ-albumin (50 mg/ml) for up to 180 min.
The cells were washed and the cell lysates divided into equal
aliquots. One aliquot was untreated as a measure of cellular
degradation of the DQ-albumin whereas the other was
incubated with trypsin to measure the maximum DQ-
albumin fluorescence in each sample. The signal in both
aliquots was measured and DQ-albumin fluorescence was
expressed as a percentage of total DQ-albumin fluorescence.
Across all time points, degradation of DQ-albumin ranged
from 37 to 45% (n¼ 5) of the total DQ-albumin amount
taken up into the cells (Figure 2d).
We next used confocal and two-photon microscopy to
determine the spatial distribution of conventional Alexa-
conjugated albumin with that of DQ-albumin. OK cells were
incubated with Alexa-albumin (25 mg/ml) and DQ-albumin
(25 mg/ml) for 2 h at 37 1C and then fixed. Confocal
microscopy revealed that the Alexa-albumin probe was
widely distributed in the cells (Figure 3ai). In contrast,
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Figure 2 | DQ-albumin in proximal tubule epithelial cells. DQ-albumin fluorescence was measured using a BMG Fluostar Optima at
550 nm excitation and 620 nm emission wavelengths. (a) OK cells were exposed to increasing amounts of DQ-albumin (20–2,000 mg/ml) for
2 h, at which time DQ-albumin fluorescence in OK cell lysates was measured (n¼ 5). (b) OK cells were exposed to DQ-albumin (50 mg/ml) in
the presence of increasing concentrations of unlabeled albumin (0–300 mg/ml) for 2 h, at which time DQ-albumin fluorescence in OK cell
lysates was measured. (c) OK cells were exposed to DQ-albumin (50mg/ml) in the absence and presence of chloroquine (5 or 100 mM) or
latrunculin A (2 mM) for 2 h, at which time DQ-albumin fluorescence in OK cell lysates was measured. (d) OK cells were incubated with
DQ-albumin (50 mg/ml) for up to 180 min. Cells lysates were divided into equal aliquots. One aliquot was untreated, whereas the other was
incubated with trypsin before measuring fluorescence. The DQ-albumin signal in the untreated samples was expressed as a percentage of
trypsinized (total) DQ-albumin fluorescence. Error bars represent the mean±s.e.m. of at least three independent experiments. **(Po0.01)
and ***(Po0.001) indicate statistically significant difference compared to control.
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DQ-albumin was mainly concentrated in larger vesicular
structures at the basolateral aspect of the cells (Figure 3aii).
Size analysis with ImageJ software revealed that the average
size of the DQ-containing vesicles was significantly larger
(43±11%; n¼ 177; Po0.01) than those containing Alexa-
albumin. Distribution analysis showed a pronounced pre-
sence of Alexa-albumin containing vesicles at the most apical
regions of the cells. In contrast, DQ-albumin vesicles were
not detected in these regions but were detected 1.5–2 mm
below the most apically located Alexa-albumin vesicles (data
not shown). This is consistent with DQ-albumin fluorescing
at a later stage of the endocytic pathway. With each probe
there was no saturation of the signal and no spectral overlap
was detected. As expected, because the Alexa-albumin is also
being degraded and the fragments that fluoresce are also
present in this subcellular location, merging of the two
signals revealed significant colocalization of the two probes in
the DQ-labeled structures (Figure 3aiii). An advantage of
two-photon microscopy over confocal microscopy is that the
image is not contaminated by fluorescence out of the focal
plane, thereby allowing a high degree of spatial resolution.
We next used two-photon microscopy with a lysosomal
marker (Lysosensor, Molecular Probes) to confirm that the
DQ-signal was associated with the degradative pathway. The
Lysosensor dyes are acidotrophic probes that accumulate in
acid vesicles. The images shown in Figure 3b clearly show
that the fluorescence from DQ-albumin colocalized with
Lysosensor confirming that liberation of the fluorescent
signal from DQ-albumin occurs within the degradative
pathway.
Visualizing albumin degradation in vivo in the kidney
Having validated the use of DQ-albumin as a probe to
measure tubular cell uptake and degradation of albumin in
vitro, we next investigated the uptake and degradation of
albumin in the rat kidney. Intravenous TR-albumin or DQ-
albumin was administered to rats by bolus injection (10 mg/g
body weight) into the tail vein. After a period of 5 min the
animals were killed and the kidneys removed immediately for
fixation and subsequent processing for confocal microscopy.
TR-albumin labeling of proximal tubules was clearly evident
5 min after intravenous injection (Figure 4a–g). TR-albumin
containing vesicles were distributed throughout the proximal
tubular cells, radiating from the tubular lumen and extending
to the basal surfaces of the tubules. In the case of DQ-
albumin, a strong signal was also observed in the proximal
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Figure 3 | Microscopic analysis of albumin endocytosis and degradation in vitro. (a) OK cells were incubated with Alexa-albumin
(25mg/ml) and DQ-albumin (25 mg/ml) for 2 h at 37 1C and then fixed. Fluorescent albumin distribution was assessed by confocal
microscopy. (b) OK cells were incubated with Lysosensor (1 mM) for 5 min, at which time DQ-albumin (50 mg/ml) was added for a further
10 min. Lysosensor and DQ-albumin localization were assessed in live cells by two-photon microscopy. Images shown are representative of
at least four independent experiments.
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tubules 5 min after intravenous injection. The fluorescence
was primarily in large vesicles, which in most tubules were
predominantly localized towards the basolateral aspect of the
cells with relatively little signal observed at the brush border.
Significantly, in rats injected with a similar concentration of a
small molecular weight fluid phase marker sulforhodamine B
(the equivalent of free fluorescent probe) we could observe
no fluorescence in the tissue sections. This indicates that the
signal observed in the TR- and DQ-albumin-injected rats is
not because of free probe. The signal could also not be
derived from degraded DQ-albumin fragments because we
showed that the DQ-albumin was not degraded in the serum
(c.f. Figure 1d above). As one further control, we performed a
purification step on the Alexa-albumin obtained from
Molecular Probes using Microcon YM-50 (Millipore,
Billerica, MA, USA) columns to remove any fragments under
50 kDa. Subsequent intravenous injection of this material
gave a fluorescence signal in tubules indistinguishable to that
seen with the standard purified Alexa-albumin preparation,
ruling out potential contamination with labeled albumin
fragments (data not shown).
DISCUSSION
Fluorescent albumin conjugates have been used for a number
of years to assess the albumin pathway as a whole, however, a
consolidated and unified description of how albuminuria
develops and how it relates to the progression of renal disease
has been problematic. The development of powerful imaging
tools such as intravital two-photon microscopy has opened a
new approach to explore renal albumin handling. One
technical drawback is that it is difficult to correlate the uptake
of conjugated albumin with its degradation. The only
methods currently available involve indirect measures of
albumin degradation, such as size-based analysis of radio-
labeled albumin in urine and serum samples,8 which provide
only total measures of albumin degradation and no
information at a cellular level.
In this study, we show that DQ-albumin probes can be
used to visualize and measure albumin degradation. Our in
vitro findings demonstrated that DQ-albumin fluorescence is
dependent on proteolytic digestion and displays saturable
kinetics. The observation that the DQ-albumin signal was
reduced in the presence of unlabeled albumin is similar to
that previously reported for fluorescein isothiocyanate-
albumin.11 and indicates that DQ-albumin is being handled
by the same pathways as for normal albumin. In a cellular
context, DQ-albumin degradation in proximal tubular
epithelial cells was reduced by inhibition of lysosomal
acidification. The fact that all the DQ-albumin fluorescence
effectively colocalized with Lysosensor is important as it
shows that the DQ-albumin can only be visualized in acid
compartments. These compartments are distinct from the
early endocytic structures that are found directly associated
with the luminal surface that are seen with normal albumin
probes. At any given time point during albumin uptake in
cultured cells, approximately 40% of the albumin is
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Figure 4 | Confocal microscopic analysis of albumin endocytosis
and degradation in vivo. Anaesthetized male Wistar rats were
injected intravenously with 10mg/g body weight of TR-albumin or
DQ-albumin in 0.5 ml of saline. After 5 min the animals were killed
and the kidneys were removed. Kidneys were fixed in neutral
buffered formalin, paraffin embedded, and sectioned at 10mm. TR-
albumin (panels a–d) and DQ-albumin (panels e–h) were visualized
by confocal microscopy. (a) TR-albumin uptake within 5 min in
proximal tubular cells. (b) Image of a single glomerulus with the early
proximal tubule leading from Bowman’s capsule containing vesicles
of TR-albumin. (c) Black and white image of the field in (b) clearly
showing the selective localization of TR-albumin to the proximal
tubule. (d) High-power view showing a widespread apical to
basolateral distribution of TR-albumin in proximal tubules (the
adjacent glomerulus is negative for TR-albumin). (e) After 5 min of
infusion, DQ-albumin fluorescence is evident in larger vesicles that
are predominant in the basolateral domain. (f) Image of a single
glomerulus with the early proximal tubule leading from Bowman’s
capsule containing vesicles of degraded (DQ-albumin). Note absence
of DQ-albumin signal in other tubular cross sections. (g) Black and
white image of the field in (f). (h) High-power view showing DQ-
albumin fluorescence predominantly at the basolateral domain of
the proximal tubules. Images shown are representative of at least
four independent experiments.
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degraded, an observation that reflects the high capacity of the
proximal tubule to absorb and degrade albumin. This
characterization of the properties of DQ-albumin extend
previous studies performed in cultured fibroblasts and
dendritic cells.13,14
Most importantly, we demonstrated that DQ-albumin is
suitable as an in vivo probe to visualize albumin degradation.
We could detect no DQ-fluorescence in the serum of the
injected rats indicating that over 5 min, there was no
significant degradation of the albumin as it circulated
through the animal. These data also argue that TR-albumin
remains intact in the circulation during the experimental
time course. Furthermore, we performed an additional
purification step on the conventional Alexa-albumin to rule
out the possibility of contamination by lower molecular
weight fragments. Thus, the fluorescence that we detect in the
proximal tubules must originate from intact albumin that has
crossed the glomerulus.
We observed readily detectable levels of TR-albumin
distributed throughout proximal tubule epithelial cells
5 min after intravenous injection. The significant DQ-
albumin fluorescent signal seen in tubules 5 min after
administration demonstrated that not only is there rapid
uptake of filtered albumin, but that the albumin is also
rapidly degraded. This is consistent with the data from
cultured proximal tubule cells. The distribution of the
TR-albumin is also similar to that reported by Ohno et al.5
who used micropuncture and confocal imaging to track
the intracellular vesicular trafficking of albumin in the
intact proximal tubule. This study is the first visualization
of renal degradation of albumin and shows that not only
are appreciable levels of albumin rapidly reabsorbed from the
glomerular filtrate, but also that the degradation of albumin
occurs with the same temporal profile. However, the
approaches used in this study are not able to temporally
dissociate albumin uptake and degradation from any
potential transcytotic pathway as proposed by Russo et al.6
In summary, because of technical limitations and different
methodologies, it remains a challenge to combine and
reconcile data regarding the molecular basis of albumin
handling by the proximal tubule and the changes that occur
in disease. This study demonstrates the utility of using DQ-
albumin conjugates to visualize albumin degradation in the
intact kidney. Importantly, this method significantly increases
the power of interpreting data obtained with conventional
fluorescent albumin conjugates to enable differentiation
between cellular compartments containing intact and de-
graded albumin. This may be a powerful tool with which to
examine alterations in tubular uptake and degradation of
albumin in diabetic nephropathy and other proteinuric
diseases.
MATERIALS AND METHODS
Reagents
DQ, Alexa488, and TR conjugates of bovine serum albumin, and
Lysosensor (blue/yellow) were obtained from Invitrogen (Carlsbad,
CA, USA). Latrunculin and chloroquine were obtained from Sigma
(St. Louis, MO, USA). All other reagents were of the highest
available purity from commercial sources.
Cell culture
The opossum proximal tubular epithelial cell line (OK; obtained
from Dr D Markovich, University of Queensland) was maintained as
previously described and albumin assays were performed under
serum free conditions.12,15,16
Albumin degradation assay
An established method for measuring albumin endocytosis in OK
cells was adapted.12,15,16 DQ-albumin fluorescence was determined
using a BMG Fluostar Optima (BMG Lab Technologies, Offenburg,
Germany) at 550 nm excitation and 620 nm emission wavelengths.
DQ-albumin degradation was adjusted for background and normal-
ized for total cellular protein.
Confocal and two-photon analysis of albumin degradation
in vitro
OK cells were seeded on glass coverslips, grown to confluency
and serum deprived. OK cells were exposed to Alexa488-albumin
(25mg/ml) and DQ-albumin (25 mg/ml) for 1 h. Cells were fixed and
then analyzed by confocal microscopy (Zeiss LSM 510 Meta confocal
microscope using  40,  63, and  100 objectives). Z-scan optical
sections were collected at 0.2mM intervals. Alexa488-albumin was
excited at 488 nm and emission was measured at 515 nm. TR-
albumin and DQ-Red-albumin were excited at 543 nm, and
emission was measured at 570 nm. For Lysosensor imaging, a
custom built two-photon microscope was utilized17 ( 40 objec-
tive). OK cells were seeded on glass coverslips, grown to confluence
and serum deprived. Live imaging was performed and OK cells were
exposed to Lysosensor (1mM) for 5 min followed by exposure to DQ-
albumin (50 mg/ml). Image processing and analysis was performed
using ImageJ (Rasband, WS, ImageJ, US National Institutes of
Health, Bethesda, MD, USA, http://rsb.info.nih.gov/ij/, 1997–2005).
Statistical significance was determined using analysis of variance on
GraphPad Prism (San Diego, CA, USA).
Animal studies
Anaesthetized male Wistar rats (200–250 g; University of Queensland
Biological Resources) were injected intravenously with 10mg/g body
weight of TR-albumin or DQ-albumin in 0.5 ml of saline or with
0.5 ml saline alone. After 5 min, a blood sample was collected, kidneys
were removed and the animals killed. Kidneys were fixed in neutral
buffered formalin, paraffin embedded and sectioned at 10mm.
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